Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine

Publisher： Karger

E-ISSN： 1662-8063|18|5|249-259

ISSN： 1662-4246

Source： Public Health Genomics, Vol.18, Iss.5, 2015-0, pp. : 249-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine

By  

Public Health Genomics, Vol. 12, Iss. 3, 2009-02 ,pp. : 163-169

Karger

Access to resources Recommend Favorite

The Disruptive Nature of Personalized Medicine Technologies: Implications for the Health Care System

By  

Public Health Genomics, Vol. 12, Iss. 3, 2009-02 ,pp. : 180-184

Karger

Access to resources Recommend Favorite

A Conceptual Framework of Mapping Access to Health Care across EU Countries: The Patient Access Initiative

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 153-159

Karger

Access to resources Recommend Favorite

Personalized Medicine in the NICU

By Barrington Keith J.  

American Journal of Bioethics, Vol. 13, Iss. 12, 2013-12 ,pp. : 33-35

Routledge Ltd

Access to resources Recommend Favorite